scispace - formally typeset
F

Francesco Cipollone

Researcher at University of Chieti-Pescara

Publications -  228
Citations -  9635

Francesco Cipollone is an academic researcher from University of Chieti-Pescara. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 49, co-authored 195 publications receiving 8335 citations. Previous affiliations of Francesco Cipollone include University of Rome Tor Vergata & University of Messina.

Papers
More filters
Journal ArticleDOI

COVID-19 and RAS: Unravelling an Unclear Relationship.

TL;DR: The renin-angiotensin system plays a main role in regulating blood pressure and electrolyte and liquid balance, and previous evidence suggests that RAS may represent an important target for the treatment of lung pathologies.
Journal ArticleDOI

COX-2 and atherosclerosis.

TL;DR: Findings from the group suggesting a crucial role for COX-2 in modulating atherosclerotic plaque stability or instability are summarized, according to the variable expression of upstream and downstream enzymes in the prostanoid biosynthesis.
Journal ArticleDOI

Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study.

Augusto Di Castelnuovo, +103 more
TL;DR: In this article, the authors evaluated if in-hospital administration of heparin improved survival in a large cohort of Italian COVID-19 patients, and they found a 40% lower risk of death in patients receiving hecarin (hazard ratio 0.60; 95% confidence interval: 0.49-0.74; E-value 2.04).
Journal ArticleDOI

Impact of migraine on fibromyalgia symptoms

TL;DR: Increased migraine frequency – with shift towards chronicity – enhances both hyperalgesia and spontaneous FMS pain, which is reversed by effective migraine prophylaxis, and results suggest different levels of central sensitization in patients with migraine, fibromyalgia or both conditions.
Journal ArticleDOI

Atorvastatin Reduces Macrophage Accumulation in Atherosclerotic Plaques A Comparison of a Nonstatin-Based Regimen in Patients Undergoing Carotid Endarterectomy

TL;DR: Short-term treatment with high-dose statin is superior to a nonstatin lipid-lowering regimen in reducing the macrophage cell content within atherosclerotic lesions, but this effect was determined by the degree of LDL-C- Lowering.